Three Factors Can ID Conservative Treatment Response in Meniere Disease
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Oct. 4, 2023 -- A clinical severity staging system has been developed that can identify treatment response for patients with Meniere disease, according to a study published online Aug. 25 in Otolaryngology-Head & Neck Surgery.
Brevin J. Miller, from the Washington University School of Medicine in St. Louis, and colleagues conducted a retrospective cohort study involving adult patients newly diagnosed with Meniere disease between Jan. 1, 2016, and Dec. 31, 2019, at a tertiary academic medical center to identify clinically important factors associated with conservative treatment response.
The researchers found that 63 and 37 percent of the 78 patients included in the study were responsive and not responsive to conservative therapies, respectively. Compared with unresponsive patients, responsive patients had higher proportions of no or mild vertigo and none or mild comorbidity and a lower proportion of hearing loss. A three-stage system was developed by performing conjunctive consolidation of these factors, with a treatment response gradient varying from 100 to 64 to 18 percent for stages 1, 2, and 3, respectively.
"This study identifies less severe vertigo, absence of hearing loss, and low comorbidity burden as clinically meaningful and readily available factors associated with conservative treatment response in patients with Meniere disease," the authors write. "The development of a composite clinical severity staging system using these factors provides novel insight regarding therapeutic response."
One author is a consultant for Cochlear Ltd.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted October 2023
Read this next
Membranous Labyrinth Distension Seen in MRI of Meniere Disease
TUESDAY, July 2, 2024 -- Distension of the membranous labyrinth is seen in histologic specimens from deceased patients with symptoms consistent with Meniere disease and in...
Sound Stimulation Aids Saccular Dysfunction With Meniere Disease
MONDAY, July 1, 2024 -- Sound stimulation of 75 dB at a frequency of 100 Hz leads to improvement in cervical vestibular-evoked myogenic potential (cVEMP) amplitude...
Bilateral Gene Therapy Safely Restores Hearing in Children Born Deaf
WEDNESDAY, June 5, 2024 -- For pediatric patients with autosomal recessive deafness 9 (DFNB9), bilateral gene therapy with adeno-associated virus (AAV) serotype 1 carrying human...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.